Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT1 | Q9H9B1 | 14/20 | 0.90 |
| ▸ | HDAC1 | Q13547 | 9/20 | 0.90 |
| ▸ | HDAC6 | Q9UBN7 | 9/20 | 0.90 |
| ▸ | EHMT2 | Q96KQ7 | 15/20 | 0.79 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.78 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.78 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.78 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.78 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.78 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.78 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.78 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.78 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.78 |
| ▸ | KDM1A | O60341 | 1/20 | 0.66 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21486557 | 1.00 | EHMT1 (0.90) | EHMT1HDAC1HDAC6EHMT2HDAC3 | |
| SCHEMBL21486551 | 1.00 | EHMT1 (0.90) | EHMT1HDAC1HDAC6EHMT2HDAC3 | |
| SCHEMBL21486569 | 0.98 | EHMT1 (0.87) | EHMT1HDAC1HDAC6EHMT2HDAC3 | |
| SCHEMBL28521596 | 0.95 | EHMT1 (1.00) | EHMT1HDAC1HDAC6EHMT2HDAC3 | |
| SCHEMBL21486546 | 0.91 | HDAC1 (0.91) | EHMT1HDAC1HDAC6EHMT2HDAC3 | |
| SCHEMBL21486548 | 0.91 | HDAC1 (0.91) | EHMT1HDAC1HDAC6EHMT2HDAC3 | |
| SCHEMBL21486539 | 0.91 | HDAC1 (0.91) | EHMT1HDAC1HDAC6EHMT2HDAC3 | |
| SCHEMBL31351168 | 0.90 | EHMT1 (0.73) | EHMT1HDAC1HDAC6EHMT2HDAC3 | |
| SCHEMBL21499812 | 0.90 | EHMT2 (0.73) | EHMT1HDAC1HDAC6EHMT2HDAC3 | |
| SCHEMBL21486692 | 0.89 | HDAC1 (0.88) | EHMT1HDAC1HDAC6EHMT2HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190322643-A1 | HISTONE DEACETYLASE AND HISTONE METHYLTRANSFERASE INHIBITORS AND METHODS OF MAKING AND USE OF THE SAME | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2019-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190322643-A1 | HISTONE DEACETYLASE AND HISTONE METHYLTRANSFERASE INHIBITORS AND METHODS OF MAKING AND USE OF THE SAME | HDAC1, HDAC2, DOT1L | EHMT1 5/4885HDAC1 1/4885HDAC6 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.